HIGHLIGHTS
- who: Qiuyue Liu from the Auckland University Technology, Maugeri), Italy have published the research work: Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients u2014A retrospective study, in the Journal: (JOURNAL)
- what: The aim this study was to evaluate endocrine therapy and chemotherapy for first-line maintenance and second-line treatment hormone receptor-positive metastatic (HR+HER-2-MBC) and the relationship between different treatment options and survival. In this analysis, the other three modes are compared with the chemotherapyendocrine therapy maintenance mode. median age . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.